Exchange: OTC·Updated 02:35 PM EST

LOBEF Lobe Sciences Ltd

$0.0359
$0.0004
(1.10%)
Today
Mkt Cap$11.06M
Vol43,274.00

About LOBEF

Lobe Sciences Ltd. is a biopharmaceutical company, which engages in the discovery and development of transformative medicines to treat rare diseases. It involves in drug research and development using non-hallucinatory doses of stabilized psilocin-based compounds to address unmet medical needs in orphan neurological therapeutic applications. The company was founded on May 13, 2010 and is headquartered in Vancouver, Canada.
50

Neutral Sentiment

How do you feel about LOBEF?

Advertisement|Remove ads.